These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31335218)

  • 21. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors for expulsion of intrauterine device Tcu380A applied immediately postpartum and after a delayed period].
    Bonilla Rosales F; Aguilar Zamudio ME; Cázares Montero Mde L; Hernández Ortiz ME; Luna Ruiz MA
    Rev Med Inst Mex Seguro Soc; 2005; 43(1):5-10. PubMed ID: 15998475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FLOW (finding lasting options for women): multicentre randomized controlled trial comparing tampons with menstrual cups.
    Howard C; Rose CL; Trouton K; Stamm H; Marentette D; Kirkpatrick N; Karalic S; Fernandez R; Paget J
    Can Fam Physician; 2011 Jun; 57(6):e208-15. PubMed ID: 21673197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of modified intrauterine device (IUD) TCu 380 with chromium filaments in the immediate postpartum].
    Hernández Valencia M; Becerril Flores LC
    Ginecol Obstet Mex; 2000 Feb; 68():70-6. PubMed ID: 10774108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insertion technique, not design, affects expulsion rates of postpartum intrauterine device.
    Stumpf PG; Lenker RM
    Contraception; 1984 Oct; 30(4):327-30. PubMed ID: 6509985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability and feasibility of using vaginal menstrual cups among schoolgirls in rural Nepal: a qualitative pilot study.
    Pokhrel D; Bhattarai S; Emgård M; von Schickfus M; Forsberg BC; Biermann O
    Reprod Health; 2021 Jan; 18(1):20. PubMed ID: 33487171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrauterine device insertion-related complications: can they be predicted?
    Farmer M; Webb A
    J Fam Plann Reprod Health Care; 2003 Oct; 29(4):227-31. PubMed ID: 14662057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current use of an intrauterine device and risk of tubal pregnancy.
    Rossing MA; Daling JR; Voigt LF; Stergachis AS; Weiss NS
    Epidemiology; 1993 May; 4(3):252-8. PubMed ID: 8512989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrauterine device use among women with uterine fibroids: a systematic review.
    Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of the IUD insertion.
    Edelman DA; Zipper J; Rivera M; Medel M
    Contraception; 1979 May; 19(5):449-54. PubMed ID: 467054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of copper intrauterine devices when inserted after an expulsion.
    Bahamondes L; Díaz J; Marchi NM; Petta CA; Cristofoletti ML; Gomez G
    Hum Reprod; 1995 Nov; 10(11):2917-8. PubMed ID: 8747044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine contraception after medical abortion: factors affecting success of early insertion.
    Pohjoranta E; Suhonen S; Mentula M; Heikinheimo O
    Contraception; 2017 Mar; 95(3):257-262. PubMed ID: 27836586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of intrauterine contraceptives].
    Parshina LA; Konishcheva OE
    Akush Ginekol (Mosk); 1977 Dec; (12):39-40. PubMed ID: 605979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.